Professional Documents
Culture Documents
Lecture A2
Toxicokinetic processes:
absorption (part-1)
NOTICE: These materials are subject to Canadian copyright and are presented here as images published in journals and books for which the University of Waterloo holds a licensed electronic
subscription. These materials are provided to HLTH 340 students for their exclusive use though a non-public courseware system (UW-LEARN) and the images are restricted to the use of HLTH
340 students. Reproduction, transmittal, copying, or posting of these images by students in any form, electronic or physical, is strictly prohibited.
W2013
W2013
toxicokinetics describes the movement of xenobiotic substances into and within the
organism subsequent to an environmental exposure
Absorption controls entry of xenobiotics through the external membrane barriers into the
blood (or lymphatic) circulation
Distribution determines the movement of xenobiotic molecules with the circuatory fluids
and specific organs and tissues
Excretion controls the removal of the xenobiotic or its metabolites from the body
W2013
W2013
W2013
Route of exposure
Route of exposure
Dermal (skin)
Inhalation (lung)
Oral (GI)
Injection
W2013
Inhalation
Intravenous
Intraperitoneal
Subcutaneous
Gastrointestinal
tract
Lung
Intramuscular
first-pass
effect
Dermal
Liver
distribution
extracellular
fluid
Kidney
Bladder
feces
W2013
absorption
Urine
Lung
Secretory
Structures
Expired Air
body
organs
soft
tissue
Alveoli
Secretions
fat
bone
excretion
7
W2013
receptor-mediated transport
(selective)
(non-selective)
transcellular
paracellular
W2013
external dose
(site of
absorption)
W2013
internal
dose
(blood)
external dose
(site of
absorption)
10
W2013
11
apical
(outside)
baso-lateral
(inside)
12
W2013
13
passive diffusion cannot concentrate substances across membrane barrier (no pumping action)
bidirectional -- flow of molecules will follow the concentration gradient in either direction (in or out of tissue)
surface area through which diffusion is occurring (membrane lining of gut, lung, and skin)
concentration gradient [Cexternal] >> [Cinternal]
permeability of the substance through the membrane barrier
molecular weight
smaller molecules (MW < 500 daltons) are often able to migrate through biomembranes by passive diffusion
over 80% of effective drugs have a MW < 450 daltons
hydrophobicity
tendency of a substance to dissolve preferentially in fatty or oily biological media, but not in water
ionization
molecules that carry positively or negatively charged functional groups have ionic properties
charged ionic groups experience electrostatic interactions with ionic phospholipid membrane groups
polarity (hydrogen bonding)
molecules with uneven electrical charge distribution (polar compounds) form H-bonds with water
W2013
14
EXTERIOR
HYDRO
PHILE
HYDRO
PHILE
polar heads
HYDRO
PHILE
LIPOPHILE
non-polar tails
Phospholipid
Bilayer
INTERIOR
FACILITATED DIFFUSION
OR
ACTIVE TRANSPORT
HYDRO
PHILE
PASSIVE
DIFFUSION
LIPOPHILE
W2013
15
W2013
16
lipophilicity factors are used to predict passive absorption of drugs and xenobiotics
W2013
17
oily non-aqueous phase solvent (octanol) and watery aqueous phase (H2O)
oil and water dont mix
Ko/w<1 is hydrophilic
W2013
example:
18
W2013
19
ko/w
ko/w
W2013
20
4-5
3
2
1
log Kp < 0 substances are
poorly absorbed due to
ionic interactions or H-bonding
hydrophilic
W2013
<0
moderately
lipophilic
0 - 0.9 mixed or
amphiphilic
21
W2013
22
W2013
23